Dr Sue Astley
University of Manchester
Sue Astley leads research in breast radiomics at the University of Manchester. Her work includes evaluation of novel imaging technologies (CAD, DBT), developing software to detect abnormalities and discover imaging biomarkers, using eye tracking to learn how new imaging systems are best employed, and working closely with radiologists to achieve clinically useful solutions. As breast density lead for the 55,000 strong Predicting Risk of Cancer At Screening (PROCAS) study she has focused her attention on markers of breast cancer risk, harnessing the power of deep learning to exploit the trial data and improve risk prediction.
Deep learning for breast density assessment and risk prediction
I will review the importance of breast density assessment for cancer risk prediction, identifying women for whom mammography is less effective, and assessing the efficacy of risk reducing interventions. I will then discuss current methods for density assessment, looking at the strengths and limitations of different approaches. Finally, I will describe density assessment using convolutional neural networks, including a review of the issues associated with developing and validating such approaches.
EVEN MORE SEMINARS
Dr. Simeon Nill The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust
MR image-guided radiotherapy treatment on the MR-Linac
Dr Serguei Semenov EMTensor GmbH
Electromagnetic tomography for brain imaging
Peter Ross Birkbeck University of London
Improving Quality of Diagnostic PET-CT Reporting: Factors Influencing Doctors’ Performance.
David Gibbins Micrima
Radio-wave breast imaging a new technology
Ernesto A. Cerdena, PhD AtlantiCare Regional Medical Center (a member of Geisinger), Atlantic City, New Jersey, USA
Challenges and Success in Adopting Clinical Decision Support Mechanism In Diagnostic Imaging